Boston Partners cut its stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 44.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,499 shares of the company's stock after selling 9,252 shares during the period. Boston Partners' holdings in Bowhead Specialty were worth $408,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the stock. New York State Common Retirement Fund bought a new position in Bowhead Specialty in the 4th quarter worth approximately $64,000. US Bancorp DE acquired a new stake in shares of Bowhead Specialty in the 4th quarter worth approximately $76,000. MetLife Investment Management LLC acquired a new stake in shares of Bowhead Specialty in the 3rd quarter worth approximately $123,000. New Vernon Investment Management LLC bought a new position in shares of Bowhead Specialty in the third quarter valued at approximately $127,000. Finally, Quantbot Technologies LP acquired a new position in shares of Bowhead Specialty during the third quarter valued at approximately $157,000.
Bowhead Specialty Stock Performance
Shares of NYSE:BOW traded up $0.71 during trading hours on Thursday, hitting $41.07. 401,860 shares of the company's stock traded hands, compared to its average volume of 194,295. The company's fifty day simple moving average is $33.85 and its two-hundred day simple moving average is $32.73. Bowhead Specialty Holdings Inc. has a 52 week low of $22.14 and a 52 week high of $41.79.
Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.07. The business had revenue of $184.77 million for the quarter, compared to the consensus estimate of $102.12 million. Analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, Keefe, Bruyette & Woods upgraded Bowhead Specialty from a "market perform" rating to an "outperform" rating and set a $44.00 target price for the company in a research report on Monday, March 3rd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Bowhead Specialty currently has an average rating of "Moderate Buy" and a consensus price target of $33.60.
Check Out Our Latest Analysis on BOW
Insider Transactions at Bowhead Specialty
In related news, Director Ava Schnidman bought 1,493 shares of the business's stock in a transaction dated Friday, February 28th. The shares were bought at an average cost of $33.41 per share, with a total value of $49,881.13. Following the completion of the transaction, the director now directly owns 1,893 shares of the company's stock, valued at approximately $63,245.13. This trade represents a 373.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
About Bowhead Specialty
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.